Aditxt, Inc. Files 8-K on Security Holder Votes
Ticker: ADTX · Form: 8-K · Filed: Apr 17, 2025 · CIK: 1726711
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: ADTX
TL;DR
ADTX filing 8-K: Shareholder vote matters are on the table.
AI Summary
Aditxt, Inc. filed an 8-K on April 17, 2025, reporting on the submission of matters to a vote of security holders. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. The filing does not contain specific financial figures or details about the matters to be voted on.
Why It Matters
This filing indicates that Aditxt, Inc. is seeking shareholder approval for certain corporate actions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial risks or significant operational changes.
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- Aditx Therapeutics, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- April 17, 2025 (date) — Date of report
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that such matters are being submitted.
When was Aditxt, Inc. formerly known as Aditx Therapeutics, Inc.?
The company's name changed from Aditx Therapeutics, Inc. on November 13, 2020.
What is Aditxt, Inc.'s primary business sector?
Aditxt, Inc. is in the Pharmaceutical Preparations sector, with SIC code 2834.
Where is Aditxt, Inc. headquartered?
Aditxt, Inc.'s principal executive offices are located at 2569 Wyandotte Street, Suite 101, Mountain View, CA 94043.
What is the filing date of this 8-K report?
The report was filed on April 17, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2025 regarding Aditxt, Inc. (ADTX).